Clinical Insights

Evidence-based perspectives on peptide therapy, hormone optimization, and functional medicine. Written by Dr. Aren Nilsson, D.C.

The GLP-1 Crackdown Is Here. Now What?
Thyroid Health

The GLP-1 Crackdown Is Here. Now What?

The FDA shut down compounded semaglutide in 2026. For millions struggling with weight loss, the real answer may be an underperforming thyroid, not another drug. Learn how fluoride, iodine deficiency, and inadequate testing are driving metabolic dysfunction.

AN
Dr. Aren Nilsson, D.C.|10 min read|April 3, 2026